NasdaqGM - Nasdaq Real Time Price USD

Vanda Pharmaceuticals Inc. (VNDA)

Compare
5.26 +0.37 (+7.46%)
As of 11:28 AM EST. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
182,022.00
192,640.00
254,382.00
268,682.00
248,168.00
Cost of Revenue
12,696.00
14,796.00
24,282.00
25,629.00
23,364.00
Gross Profit
169,326.00
177,844.00
230,100.00
243,053.00
224,804.00
Operating Expense
201,796.00
191,796.00
223,771.00
200,888.00
197,565.00
Operating Income
-32,470.00
-13,952.00
6,329.00
42,165.00
27,239.00
Other Income Expense
20,509.00
20,291.00
4,971.00
199.00
4,416.00
Pretax Income
-11,961.00
6,339.00
11,300.00
42,364.00
31,655.00
Tax Provision
-1,034.00
3,830.00
5,025.00
9,212.00
8,318.00
Net Income Common Stockholders
-10,927.00
2,509.00
6,275.00
33,152.00
23,337.00
Diluted NI Available to Com Stockholders
-10,927.00
2,509.00
6,275.00
33,152.00
23,337.00
Basic EPS
-0.19
0.04
0.11
0.60
0.43
Diluted EPS
-0.19
0.04
0.11
0.58
0.42
Basic Average Shares
57,759.48
57,380.98
56,461.88
55,548.12
54,427.68
Diluted Average Shares
57,818.80
57,557.91
56,983.17
56,921.84
55,190.80
Total Operating Income as Reported
-32,470.00
-13,952.00
6,329.00
42,165.00
27,239.00
Total Expenses
214,492.00
206,592.00
248,053.00
226,517.00
220,929.00
Net Income from Continuing & Discontinued Operation
-10,927.00
2,509.00
6,275.00
33,152.00
23,337.00
Normalized Income
-10,927.00
2,509.00
6,275.00
33,152.00
23,337.00
EBIT
-32,470.00
-13,952.00
6,329.00
42,165.00
27,239.00
EBITDA
-26,540.00
-10,942.00
9,062.00
45,006.00
30,103.00
Reconciled Cost of Revenue
11,869.00
13,876.00
23,065.00
24,266.00
21,978.00
Reconciled Depreciation
5,930.00
3,010.00
2,733.00
2,841.00
2,864.00
Net Income from Continuing Operation Net Minority Interest
-10,927.00
2,509.00
6,275.00
33,152.00
23,337.00
Normalized EBITDA
-26,540.00
-10,942.00
9,062.00
45,006.00
30,103.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 4/12/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers